Syöpätautien yksikkö
Department of Oncology

Julkaisut 2005
Publications 2005

Lisätietoja julkaisusta saa klikkaamalla sen numeroa.
For full details, please click the number in front of the publication.


1 Auvinen P et al. Expression of CD44s, CD44v3 and CD44v6 in benign and malignant breast lesions:correlation and colocalization with hyaluronan.
2 Bergh J., Kataja V. . ESMO Minium Clinical Recommendations for diagnosis,treatment and follow-up prostate cancer.
3 Hartikainen JM et al. An autosome-wide scan for linkage disequilibrium-based association in sporadic breast cancer cases in Eastern Finland: three candidate regions found.
4 Herrstedt J et al. ESMO Minium Clinical Recommendations for prophylaxis of chemotheapy-induced nausea and vomitting.
5 Huddart R.A, Kataja V. ESMO Minium Clinical Recommendations for diagnosis,treatment and follow-up of testicular seminoma.
6 Johansson R. Adverse effects of antineoplastic drugs .
7 Kataja V. Book reviews: Neal AJ, Hoskin PJ: Clinical Oncology - Basic Principles and Practice. 3rd edition.
8 Kataja V. Solunsalpaajahoito rintasyövän eri vaiheissa.
9 Kataja V et al. ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of locally recurrent or metastatic brast cancer (MBC).
10 Koskela AK et al. Add-on device for stereotactic core-needle breast biopsy: how many biopsy specimens are needed for a reliable diagnosis?
11 Metsola K et al. XRCC1 and XPD genetic polymorphisms, smoking and breast cancer risk in the Finnish case-control study.
12 Mustonen P et al. Recurrences after immediate reconstruction in breast cancer.
13 Pavlidis N, Kataja V. ESMO Minium Clinical Recommendations for diagnosis,treatment and follow-up of invasive bladder cancer.
14 Pirinen R et al. Versican in nonsmall cell lung cancer: relation to hyaluronan, clinicopathologic factors, and prognosis.
15 Pivot X et al. ESMO Minium Clinical Recommendations for diagnosis,treatment and follow-up of squamous cell carcinoma of the head and neck.
16 Sillanpää P et al. NAT2 slow acetylator genotype as an important modifier of breast cancer risk.
17 Sillanpää P et al. Sulfotransferase 1A1 genotype as a potential modifier of breast cancer risk among premenopausal women.
18 Stahl M et al. ESMO Minimal Clinical Recommendations for diagnosis,treatment and follow-up of esophageal cancer.
19 Tveit K. M, Kataja V. ESMO Minium Clinical Recommendations for diagnosis,treatment and follow-up of rectal cancer.
20 Van Custem E.J.D. et al. ESMO Minium Clinical Recommendations for diagnosis,treatment and follow-up of advanced colorectal cancer.
21 Van Cutsem E.J.D, Kataja V. ESMO Minium Clinical Recommendations for diagnosis,adjuvant treatment and follow-up of colon cancer.

Syöpätautien yksikkö Department of Oncology
Julkaisutietokanta 15.4.2008 Publications Data Base 15.4.2008